These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4960134)

  • 1. Relationships between the copper atoms of caeruloplasmin. II. An interaction between the copper binding sites.
    Marriott J; Perkins DJ
    Biochim Biophys Acta; 1966 Apr; 117(2):395-402. PubMed ID: 4960134
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationships between the copper atoms of caeruloplasmin. I. Studies on the exchange of 64 Cu with caeruloplasmin.
    Marriott J; Perkins DJ
    Biochim Biophys Acta; 1966 Apr; 117(2):387-94. PubMed ID: 5961304
    [No Abstract]   [Full Text] [Related]  

  • 3. [HEPATOCEREBRAL OR HEPATOLENTICULAR DEGENERATION].
    AKSOY M; BIYAL F; SECER F; CAKIRGOEZ C; CETINGIL AI
    Tip Fak Mecm; 1964; 27():37-55. PubMed ID: 14140395
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationships between the copper atoms of caeruloplasmin. 3. A difference in the reactivity of the chromophoric sites.
    Marriott J; Perkins DJ
    Biochim Biophys Acta; 1968 Apr; 154(3):501-6. PubMed ID: 5650417
    [No Abstract]   [Full Text] [Related]  

  • 5. PHYSICAL AND CHEMICAL STUDIES ON CERULOPLASMIN. 3. A STABILIZING COPPER-COPPER INTERACTION IN CERULOPLASMIN.
    ISEN P; MORELL AG
    J Biol Chem; 1965 May; 240():1974-8. PubMed ID: 14299617
    [No Abstract]   [Full Text] [Related]  

  • 6. [CURRENT ASPECTS OF WILSON'S DISEASE].
    PETIT H
    Lille Med; 1964 Oct; 9():750-8. PubMed ID: 14210920
    [No Abstract]   [Full Text] [Related]  

  • 7. [OUR EXPERIENCE IN THE TREATMENT OF WILSON'S DISEASE WITH PENICILLAMINE].
    BOUDIN G; PEPIN B; LAURAS A; BARRAINE R
    Rev Neurol (Paris); 1963 Jul; 109():82-6. PubMed ID: 14091678
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ceruloplasmin and immunoglobulins under controlled D-penicillamine therapy in rheumatoid arthritis].
    Schmidt KL; Ott VR
    Z Rheumatol; 1976; 35(3-4):154-63. PubMed ID: 1266422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The subunit structure of porcine ceruloplasmin.
    Mukasa H; Kajiyama S; Sugiyama K; Funakubo K; Itoh M; Nosoh Y; Sato T
    Biochim Biophys Acta; 1968 Sep; 168(1):132-42. PubMed ID: 4971762
    [No Abstract]   [Full Text] [Related]  

  • 10. The oxidation of NN-dimethyl-p-phenylenediamine by oxidizing agents and by caeruloplasmin.
    Curzon G
    Biochem J; 1967 May; 103(2):289-98. PubMed ID: 6032975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HEPATO-LENTICULAR DEGENERATION (WILSON'S DISEASE) TREATED BY PENICILLAMINE.
    RICHMOND J; ROSENOER VM; TOMPSETT SL; DRAPER I; SIMPSON JA
    Brain; 1964 Dec; 87():619-38. PubMed ID: 14236007
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of photooxidation on hum caeruloplasmin.
    Bannister WH; Wood EJ
    Eur J Biochem; 1969 Nov; 11(1):179-82. PubMed ID: 4982090
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of inhibitor mixtures and the specific effects of different anions on the oxidase activity of caeruloplasmin.
    Curzon G; Speyer BE
    Biochem J; 1968 Aug; 109(1):25-34. PubMed ID: 5669845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition of caeruloplasmin by azide.
    Curzon G
    Biochem J; 1966 Aug; 100(2):295-302. PubMed ID: 4961299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of the copper states of porcine ceruloplasmin by urea denaturation.
    Mukasa H; Noso Y; Sato T
    J Biochem; 1969 Apr; 65(4):649-50. PubMed ID: 4979713
    [No Abstract]   [Full Text] [Related]  

  • 16. Does copper-D-penicillamine catalyze the dismutation of O2-?
    Robertson P; Fridovich I
    Arch Biochem Biophys; 1980 Sep; 203(2):830-1. PubMed ID: 6257182
    [No Abstract]   [Full Text] [Related]  

  • 17. [Wilson's disease (hepatolenticular degeneration)].
    Bickel H
    Internist (Berl); 1966 Jan; 7(1):27-33 passim. PubMed ID: 4964272
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatolenticular degeneration: biochemical and therapeutic considerations].
    Clin Ter; 1976 Mar; 76(6):567-76. PubMed ID: 828082
    [No Abstract]   [Full Text] [Related]  

  • 19. The ascorbate oxidase activity of caeruloplasmin.
    Curzon G; Young SN
    Biochim Biophys Acta; 1972 Apr; 268(1):41-8. PubMed ID: 4622934
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of hepatolenticular degeneration. (Wilson's disease).
    Spellberg MA
    Am J Gastroenterol; 1969 Aug; 52(2):121-6. PubMed ID: 4979739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.